-
1
-
-
0037025356
-
AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling
-
Bolster D.R., Crozier S.J., Kimball S.R., et al. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem. 2002, 277:23977-23980.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 23977-23980
-
-
Bolster, D.R.1
Crozier, S.J.2
Kimball, S.R.3
-
2
-
-
67349122064
-
Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells
-
Brito P.M., Devillard R., Negre-Salvayre A., et al. Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis 2009, 205:126-134.
-
(2009)
Atherosclerosis
, vol.205
, pp. 126-134
-
-
Brito, P.M.1
Devillard, R.2
Negre-Salvayre, A.3
-
3
-
-
0035491792
-
Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression
-
Brunmair B., Gras F., Neschen S., et al. Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression. Diabetes 2001, 50:2309-2315.
-
(2001)
Diabetes
, vol.50
, pp. 2309-2315
-
-
Brunmair, B.1
Gras, F.2
Neschen, S.3
-
4
-
-
0035860237
-
The regulation of AMP-activated protein kinase by H(2)O(2)
-
Choi S.L., Kim S.J., Lee K.T., et al. The regulation of AMP-activated protein kinase by H(2)O(2). Biochem. Biophys. Res. Commun. 2001, 287:92-97.
-
(2001)
Biochem. Biophys. Res. Commun.
, vol.287
, pp. 92-97
-
-
Choi, S.L.1
Kim, S.J.2
Lee, K.T.3
-
5
-
-
50649108650
-
Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo
-
Choi H.C., Song P., Xie Z., et al. Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo. J. Biol. Chem. 2008, 283:20186-20197.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 20186-20197
-
-
Choi, H.C.1
Song, P.2
Xie, Z.3
-
6
-
-
0027326421
-
Effect of the nifedipine-atenolol association on arterial myocyte migration and proliferation
-
Corsini A., Quarato P., Raiteri M., et al. Effect of the nifedipine-atenolol association on arterial myocyte migration and proliferation. Pharmacol. Res. 1993, 27:299-307.
-
(1993)
Pharmacol. Res.
, vol.27
, pp. 299-307
-
-
Corsini, A.1
Quarato, P.2
Raiteri, M.3
-
7
-
-
10544246073
-
Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes
-
Corsini A., Bonfatti M., Quarato P., et al. Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes. J. Cardiovasc. Pharmacol. 1996, 28:687-694.
-
(1996)
J. Cardiovasc. Pharmacol.
, vol.28
, pp. 687-694
-
-
Corsini, A.1
Bonfatti, M.2
Quarato, P.3
-
8
-
-
33644747421
-
Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase
-
Davis B.J., Xie Z., Viollet B., et al. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006, 55:496-505.
-
(2006)
Diabetes
, vol.55
, pp. 496-505
-
-
Davis, B.J.1
Xie, Z.2
Viollet, B.3
-
9
-
-
77149134285
-
Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo
-
Dong Y., Zhang M., Liang B., et al. Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation 2010, 121:792-803.
-
(2010)
Circulation
, vol.121
, pp. 792-803
-
-
Dong, Y.1
Zhang, M.2
Liang, B.3
-
11
-
-
0037067666
-
The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways
-
Fryer L.G., Parbu-Patel A., Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 2002, 277:25226-25232.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 25226-25232
-
-
Fryer, L.G.1
Parbu-Patel, A.2
Carling, D.3
-
13
-
-
0028365310
-
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
-
Griendling K.K., Minieri C.A., Ollerenshaw J.D., et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994, 74:1141-1148.
-
(1994)
Circ. Res.
, vol.74
, pp. 1141-1148
-
-
Griendling, K.K.1
Minieri, C.A.2
Ollerenshaw, J.D.3
-
14
-
-
77949834465
-
Development of novel adenosine monophosphate-activated protein kinase activators
-
Guh J.H., Chang W.L., Yang J., et al. Development of novel adenosine monophosphate-activated protein kinase activators. J. Med. Chem. 2010, 53:2552-2561.
-
(2010)
J. Med. Chem.
, vol.53
, pp. 2552-2561
-
-
Guh, J.H.1
Chang, W.L.2
Yang, J.3
-
15
-
-
0031717105
-
The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?
-
Hardie D.G., Carling D., Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?. Annu. Rev. Biochem. 1998, 67:821-855.
-
(1998)
Annu. Rev. Biochem.
, vol.67
, pp. 821-855
-
-
Hardie, D.G.1
Carling, D.2
Carlson, M.3
-
16
-
-
0028845251
-
2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms
-
2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J. Biol. Chem. 1995, 270:27186-27191.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 27186-27191
-
-
Hawley, S.A.1
Selbert, M.A.2
Goldstein, E.G.3
-
17
-
-
0036324142
-
The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism
-
Hawley S.A., Gadalla A.E., Olsen G.S., et al. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 2002, 51:2420-2425.
-
(2002)
Diabetes
, vol.51
, pp. 2420-2425
-
-
Hawley, S.A.1
Gadalla, A.E.2
Olsen, G.S.3
-
18
-
-
0029005507
-
Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase
-
Henin N., Vincent M.F., Gruber H.E., et al. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J. 1995, 9:541-546.
-
(1995)
FASEB J.
, vol.9
, pp. 541-546
-
-
Henin, N.1
Vincent, M.F.2
Gruber, H.E.3
-
19
-
-
0034528377
-
Nifedipine suppresses neointimal thickening by its inhibitory effect on vascular smooth muscle cell growth via a MEK-ERK pathway coupling with Pyk2
-
Hirata A., Igarashi M., Yamaguchi H., et al. Nifedipine suppresses neointimal thickening by its inhibitory effect on vascular smooth muscle cell growth via a MEK-ERK pathway coupling with Pyk2. Br. J. Pharmacol. 2000, 131:1521-1530.
-
(2000)
Br. J. Pharmacol.
, vol.131
, pp. 1521-1530
-
-
Hirata, A.1
Igarashi, M.2
Yamaguchi, H.3
-
20
-
-
23844471263
-
2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases
-
2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 2005, 280:29060-29066.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 29060-29066
-
-
Hurley, R.L.1
Anderson, K.A.2
Franzone, J.M.3
-
21
-
-
26844527037
-
Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression
-
Igata M., Motoshima H., Tsuruzoe K., et al. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ. Res. 2005, 97:837-844.
-
(2005)
Circ. Res.
, vol.97
, pp. 837-844
-
-
Igata, M.1
Motoshima, H.2
Tsuruzoe, K.3
-
22
-
-
33748153690
-
TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth
-
Inoki K., Ouyang H., Zhu T., et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006, 126:955-968.
-
(2006)
Cell
, vol.126
, pp. 955-968
-
-
Inoki, K.1
Ouyang, H.2
Zhu, T.3
-
23
-
-
78650898669
-
Tumor suppressor serine/threonine kinase LKB1 expression, not kinase activity, increased in the vascular smooth muscle cells and neointima in the rat carotid artery injury model
-
Jeong J.O., Kim J.H., Ahn K.T., et al. Tumor suppressor serine/threonine kinase LKB1 expression, not kinase activity, increased in the vascular smooth muscle cells and neointima in the rat carotid artery injury model. Korean Circ. J. 2010, 40:552-557.
-
(2010)
Korean Circ. J.
, vol.40
, pp. 552-557
-
-
Jeong, J.O.1
Kim, J.H.2
Ahn, K.T.3
-
24
-
-
78649367703
-
Losartan inhibits vascular smooth muscle cell proliferation through activation of AMP-activated protein kinase
-
Kim J.E., Choi H.C. Losartan inhibits vascular smooth muscle cell proliferation through activation of AMP-activated protein kinase. Korean J. Physiol. Pharmacol. 2010, 14:299-304.
-
(2010)
Korean J. Physiol. Pharmacol.
, vol.14
, pp. 299-304
-
-
Kim, J.E.1
Choi, H.C.2
-
25
-
-
65249124172
-
Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation
-
Kim S.Y., Jeoung N.H., Oh C.J., et al. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation. Circ. Res. 2009, 104:842-850.
-
(2009)
Circ. Res.
, vol.104
, pp. 842-850
-
-
Kim, S.Y.1
Jeoung, N.H.2
Oh, C.J.3
-
26
-
-
20044372016
-
Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells
-
Konrad D., Rudich A., Bilan P.J., et al. Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells. Diabetologia 2005, 48:954-966.
-
(2005)
Diabetologia
, vol.48
, pp. 954-966
-
-
Konrad, D.1
Rudich, A.2
Bilan, P.J.3
-
27
-
-
77951971550
-
Perivascular fat-mediated vascular dysfunction and remodeling through the AMPK/mTOR pathway in high-fat diet-induced obese rats
-
Ma L., Ma S., He H., et al. Perivascular fat-mediated vascular dysfunction and remodeling through the AMPK/mTOR pathway in high-fat diet-induced obese rats. Hypertens. Res. 2010, 33:446-453.
-
(2010)
Hypertens. Res.
, vol.33
, pp. 446-453
-
-
Ma, L.1
Ma, S.2
He, H.3
-
28
-
-
3342915617
-
AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation
-
Nagata D., Takeda R., Sata M., et al. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 2004, 110:444-451.
-
(2004)
Circulation
, vol.110
, pp. 444-451
-
-
Nagata, D.1
Takeda, R.2
Sata, M.3
-
29
-
-
77954831536
-
AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation
-
Ning J., Clemmons D.R. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. Mol. Endocrinol. 2010, 24:1218-1229.
-
(2010)
Mol. Endocrinol.
, vol.24
, pp. 1218-1229
-
-
Ning, J.1
Clemmons, D.R.2
-
30
-
-
79960553358
-
Compound C inhibits vascular smooth muscle cell proliferation and migration in an AMP-activated protein kinase-independent fashion
-
Peyton K.J., Yu Y., Yates B., et al. Compound C inhibits vascular smooth muscle cell proliferation and migration in an AMP-activated protein kinase-independent fashion. J. Pharmacol. Exp. Ther. 2011, 338:476-484.
-
(2011)
J. Pharmacol. Exp. Ther.
, vol.338
, pp. 476-484
-
-
Peyton, K.J.1
Yu, Y.2
Yates, B.3
-
31
-
-
0027241856
-
The pathogenesis of atherosclerosis: a perspective for the 1990s
-
Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
-
(1993)
Nature
, vol.362
, pp. 801-809
-
-
Ross, R.1
-
32
-
-
0033552883
-
Atherosclerosis-an inflammatory disease
-
Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
-
(1999)
N. Engl. J. Med.
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
33
-
-
11144283703
-
Metabolic activation of AMP kinase in vascular smooth muscle
-
Rubin L.J., Magliola L., Feng X., et al. Metabolic activation of AMP kinase in vascular smooth muscle. J. Appl. Physiol. 2005, 98:296-306.
-
(2005)
J. Appl. Physiol.
, vol.98
, pp. 296-306
-
-
Rubin, L.J.1
Magliola, L.2
Feng, X.3
-
34
-
-
85047691317
-
CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations
-
Scott J.W., Hawley S.A., Green K.A., et al. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest. 2004, 113:274-284.
-
(2004)
J. Clin. Invest.
, vol.113
, pp. 274-284
-
-
Scott, J.W.1
Hawley, S.A.2
Green, K.A.3
-
35
-
-
67749111502
-
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
-
Shackelford D.B., Shaw R.J. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer 2009, 9:563-575.
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 563-575
-
-
Shackelford, D.B.1
Shaw, R.J.2
-
36
-
-
28844433635
-
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
-
Shaw R.J., Lamia K.A., Vasquez D., et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310:1642-1646.
-
(2005)
Science
, vol.310
, pp. 1642-1646
-
-
Shaw, R.J.1
Lamia, K.A.2
Vasquez, D.3
-
37
-
-
81355160428
-
AMPK{alpha}2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells
-
Oct 6. [Electronic publication ahead of print]
-
Song P., Wang S., He C., et al. AMPK{alpha}2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells. Circ. Res. 2011, Oct 6. [Electronic publication ahead of print].
-
(2011)
Circ. Res.
-
-
Song, P.1
Wang, S.2
He, C.3
-
38
-
-
79955663918
-
Aspirin-induced AMP-activated protein kinase activation regulates the proliferation of vascular smooth muscle cells from spontaneously hypertensive rats
-
Sung J.Y., Choi H.C. Aspirin-induced AMP-activated protein kinase activation regulates the proliferation of vascular smooth muscle cells from spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 2011, 408:312-317.
-
(2011)
Biochem. Biophys. Res. Commun.
, vol.408
, pp. 312-317
-
-
Sung, J.Y.1
Choi, H.C.2
-
39
-
-
84856281358
-
Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway
-
Jun 25. [Electronic publication ahead of print]
-
Sung J.Y., Choi H.C. Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway. Vascul. Pharmacol. 2011, Jun 25. [Electronic publication ahead of print].
-
(2011)
Vascul. Pharmacol.
-
-
Sung, J.Y.1
Choi, H.C.2
-
41
-
-
68049129864
-
In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I
-
Wang S., Xu J., Song P., et al. In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I. Diabetes 2009, 58:1893-1901.
-
(2009)
Diabetes
, vol.58
, pp. 1893-1901
-
-
Wang, S.1
Xu, J.2
Song, P.3
-
42
-
-
0026782061
-
Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase
-
Witters L.A., Kemp B.E. Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase. J. Biol. Chem. 1992, 267:2864-2867.
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 2864-2867
-
-
Witters, L.A.1
Kemp, B.E.2
-
43
-
-
10744230065
-
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
-
Woods A., Johnstone S.R., Dickerson K., et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003, 13:2004-2008.
-
(2003)
Curr. Biol.
, vol.13
, pp. 2004-2008
-
-
Woods, A.1
Johnstone, S.R.2
Dickerson, K.3
-
44
-
-
58149236965
-
Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling
-
Wu J.R., Liou S.F., Lin S.W., et al. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling. Pharmacol. Res. 2009, 59:48-56.
-
(2009)
Pharmacol. Res.
, vol.59
, pp. 48-56
-
-
Wu, J.R.1
Liou, S.F.2
Lin, S.W.3
-
45
-
-
33751229931
-
A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway
-
Xie M., Zhang D., Dyck J.R., et al. A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17378-17383.
-
(2006)
Proc. Natl. Acad. Sci. U. S. A.
, vol.103
, pp. 17378-17383
-
-
Xie, M.1
Zhang, D.2
Dyck, J.R.3
-
46
-
-
0035903028
-
Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice
-
Ylikorkala A., Rossi D.J., Korsisaari N., et al. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science 2001, 293:1323-1326.
-
(2001)
Science
, vol.293
, pp. 1323-1326
-
-
Ylikorkala, A.1
Rossi, D.J.2
Korsisaari, N.3
-
47
-
-
39449120283
-
Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide
-
Zhang M., Dong Y., Xu J., et al. Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide. Circ. Res. 2008, 102:328-337.
-
(2008)
Circ. Res.
, vol.102
, pp. 328-337
-
-
Zhang, M.1
Dong, Y.2
Xu, J.3
-
48
-
-
0034773404
-
Role of AMP-activated protein kinase in mechanism of metformin action
-
Zhou G., Myers R., Li Y., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 2001, 108:1167-1174.
-
(2001)
J. Clin. Invest.
, vol.108
, pp. 1167-1174
-
-
Zhou, G.1
Myers, R.2
Li, Y.3
-
49
-
-
0141706665
-
Activation of 5'-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite
-
Zou M.H., Hou X.Y., Shi C.M., et al. Activation of 5'-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. J. Biol. Chem. 2003, 278:34003-34010.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 34003-34010
-
-
Zou, M.H.1
Hou, X.Y.2
Shi, C.M.3
-
50
-
-
6344292389
-
Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species
-
Zou M.H., Kirkpatrick S.S., Davis B.J., et al. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J. Biol. Chem. 2004, 279:43940-43951.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 43940-43951
-
-
Zou, M.H.1
Kirkpatrick, S.S.2
Davis, B.J.3
|